Display Settings:

Format

Send to:

Choose Destination
Eur J Prev Cardiol. 2012 Jun 27;21(6):727-738. [Epub ahead of print]

Prognostic value of reported chest pain for cardiovascular risk stratification in primary care.

Author information

  • 1Department of Internal Medicine III, Cardiology, Goethe-University Frankfurt, Germany.
  • 2Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany.
  • 3Max Planck Institute of Psychiatry, Munich, Germany.
  • 4Department of Medicine I, University of Schleswig-Holstein, Campus Lübeck, Germany.
  • 5Cardiology Practice and Hospital, Munich, Germany.
  • 6Synlab Center of Laboratory Diagnostics, Heidelberg, Germany.
  • 7Department of Internal Medicine III, Cardiology, Goethe-University Frankfurt, Germany Zeiher@em.uni-frankfurt.de.

Abstract

BACKGROUND:

The prognostic significance of chest pain is well established in patients with coronary artery disease, but still ill defined in primary prevention. Therefore, the aim of our analysis was to assess the prognostic value of different forms of chest pain in a large cohort of primary care subjects under the conditions of contemporary modalities of care in primary prevention, including measurement of serum levels of the biomarker NT-pro-BNP.

DESIGN:

We carried out a post-hoc analysis of the prospective DETECT cohort study.

METHODS:

In a total of 5570 unselected subjects, free of coronary artery disease, within the 55,518 participants of the cross-sectional DETECT study, we assessed chest pain history by a comprehensive questionnaire and measured serum NT-pro-BNP levels. Three types of chest pain, which were any chest pain, exertional chest pain and classical angina, were defined. Major adverse cardiovascular events (MACEs = cardiovascular death, myocardial infarction, coronary revascularization procedures) were assessed during a 5-year follow-up period.

RESULTS:

During follow-up, 109 subjects experienced a MACE. All types of reported chest pain were associated with an approximately three-fold increased risk for the occurrence of incident MACEs, even after adjusting for cardiovascular risk factors. Any form of reported chest pain had a similar predictive value for MACEs as a one-time measurement of NT-pro-BNP. However, adding a single measurement of NT-pro-BNP and the information on chest pain resulted in reclassification of approximately 40% of subjects, when compared with risk prediction based on established cardiovascular risk factors.

CONCLUSIONS:

In primary prevention, self-reported chest pain and a single measurement of NT-pro-BNP substantially improve cardiovascular risk prediction and allow for risk reclassification of approximately 40% of the subjects compared with assessing classical cardiovascular risk factors alone.

© The European Society of Cardiology 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

KEYWORDS:

NT-pro-BNP; Self-reported chest pain; primary prevention; risk prediction

PMID:
22739685
[PubMed - as supplied by publisher]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk